#METABOLOMICS WORKBENCH spinelli_lab_20240812_130753 DATATRACK_ID:5095 STUDY_ID:ST003404 ANALYSIS_ID:AN005586 PROJECT_ID:PR001988
VERSION             	1
CREATED_ON             	August 13, 2024, 7:33 am
#PROJECT
PR:PROJECT_TITLE                 	Rhodoquinone is an Electron Carrier in the Mammalian Electron Transport Chain
PR:PROJECT_SUMMARY               	Ubiquinone (UQ), the only known electron carrier in the mammalian electron
PR:PROJECT_SUMMARY               	transport chain (ETC), delivers electrons to both oxygen (O2) and fumarate as
PR:PROJECT_SUMMARY               	terminal electron acceptors. As fumarate has a lower reduction potential than
PR:PROJECT_SUMMARY               	UQ, fumarate reduction is only thermodynamically favorable when ubiquinol, the
PR:PROJECT_SUMMARY               	reduced form of UQ, accumulates. Paradoxically, some tissues reduce fumarate
PR:PROJECT_SUMMARY               	without ubiquinol buildup, suggesting another mechanism enables fumarate
PR:PROJECT_SUMMARY               	reduction in mammals. Here, we identify rhodoquinone (RQ), a novel component of
PR:PROJECT_SUMMARY               	the mammalian ETC that carries electrons to fumarate, instead of O2, as the
PR:PROJECT_SUMMARY               	terminal electron acceptor. RQ, which is undetectable in cultured mammalian
PR:PROJECT_SUMMARY               	cells, is enriched in mitochondria from mouse and human tissues that catalyze
PR:PROJECT_SUMMARY               	high levels of fumarate reduction. UQ and RQ-directed ETC circuits support
PR:PROJECT_SUMMARY               	unique programs of mitochondrial function. Through expression of a bacterial
PR:PROJECT_SUMMARY               	enzyme that converts UQ into RQ and development of a novel RQ analog, we
PR:PROJECT_SUMMARY               	demonstrate that reprogramming the mammalian ETC from the UQ to RQ circuit
PR:PROJECT_SUMMARY               	renders cells highly resistant to hypoxia exposure in vitro and in vivo. Thus,
PR:PROJECT_SUMMARY               	we establish RQ as a fundamental component of the mammalian ETC and unveil that
PR:PROJECT_SUMMARY               	reprogramming the ETC to the RQ-circuit is a tractable strategy to ameliorate
PR:PROJECT_SUMMARY               	hypoxia-related conditions.
PR:INSTITUTE                     	UMass Chan Medical School
PR:LAST_NAME                     	UMass Chan
PR:FIRST_NAME                    	Spinelli Lab
PR:ADDRESS                       	55 Lake Avenue North, Worcester, Massachusetts, 01605, USA
PR:EMAIL                         	spinellilab@gmail.com
PR:PHONE                         	(508) 856-8989 ext. 68148
#STUDY
ST:STUDY_TITLE                   	Aspartate Tracing in SDHB KO RquA 143B Cells
ST:STUDY_SUMMARY                 	143B cells that were cloned to have the SDHB(succinate dehydrogenase complex
ST:STUDY_SUMMARY                 	iron sulfur subunit B) KO and expression of the RquA enzyme were used to check
ST:STUDY_SUMMARY                 	for mitochondrial function of DHODH(dihydroorotate dehydrogenase). Cells were in
ST:STUDY_SUMMARY                 	culture for 4 days and then extracted for polar metabolites. Cells were treated
ST:STUDY_SUMMARY                 	with DMSO and brequinar. WT and RquA 143B cells were also used for comparison.
ST:INSTITUTE                     	UMass Chan Medical School
ST:LAST_NAME                     	UMass Chan
ST:FIRST_NAME                    	Spinelli Lab
ST:ADDRESS                       	55 Lake Avenue North, Worcester, Massachusetts, 01605, USA
ST:EMAIL                         	spinellilab@gmail.com
ST:PHONE                         	(508) 856-8989 ext. 68148
#SUBJECT
SU:SUBJECT_TYPE                  	Cultured cells
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
#FACTORS
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	WT DMSO 1	Sample source:143b Cells | Sample source:WT | Treatment:DMSO	RAW_FILE_NAME(File Name )=20240809_JV141_01
SUBJECT_SAMPLE_FACTORS           	-	WT DMSO 2	Sample source:143b Cells | Sample source:WT | Treatment:DMSO	RAW_FILE_NAME(File Name )=20240809_JV141_02
SUBJECT_SAMPLE_FACTORS           	-	WT DMSO 3	Sample source:143b Cells | Sample source:WT | Treatment:DMSO	RAW_FILE_NAME(File Name )=20240809_JV141_03
SUBJECT_SAMPLE_FACTORS           	-	WT Breq 1	Sample source:143b Cells | Sample source:WT | Treatment:Brequinar	RAW_FILE_NAME(File Name )=20240809_JV141_04
SUBJECT_SAMPLE_FACTORS           	-	WT Breq 2	Sample source:143b Cells | Sample source:WT | Treatment:Brequinar	RAW_FILE_NAME(File Name )=20240809_JV141_05
SUBJECT_SAMPLE_FACTORS           	-	WT Breq 3	Sample source:143b Cells | Sample source:WT | Treatment:Brequinar	RAW_FILE_NAME(File Name )=20240809_JV141_06
SUBJECT_SAMPLE_FACTORS           	-	RquA DMSO 1	Sample source:143b Cells | Sample source:RquA | Treatment:DMSO	RAW_FILE_NAME(File Name )=20240809_JV141_07
SUBJECT_SAMPLE_FACTORS           	-	RquA DMSO 2	Sample source:143b Cells | Sample source:RquA | Treatment:DMSO	RAW_FILE_NAME(File Name )=20240809_JV141_08
SUBJECT_SAMPLE_FACTORS           	-	RquA DMSO 3	Sample source:143b Cells | Sample source:RquA | Treatment:DMSO	RAW_FILE_NAME(File Name )=20240809_JV141_09
SUBJECT_SAMPLE_FACTORS           	-	RquA Breq 1	Sample source:143b Cells | Sample source:RquA | Treatment:Brequinar	RAW_FILE_NAME(File Name )=20240809_JV141_10
SUBJECT_SAMPLE_FACTORS           	-	RquA Breq 2	Sample source:143b Cells | Sample source:RquA | Treatment:Brequinar	RAW_FILE_NAME(File Name )=20240809_JV141_11
SUBJECT_SAMPLE_FACTORS           	-	RquA Breq 3	Sample source:143b Cells | Sample source:RquA | Treatment:Brequinar	RAW_FILE_NAME(File Name )=20240809_JV141_12
SUBJECT_SAMPLE_FACTORS           	-	SDHB KO RquA DMSO 1	Sample source:143b Cells | Sample source:SDHB KO RquA | Treatment:DMSO	RAW_FILE_NAME(File Name )=20240809_JV141_13
SUBJECT_SAMPLE_FACTORS           	-	SDHB KO RquA DMSO 2	Sample source:143b Cells | Sample source:SDHB KO RquA | Treatment:DMSO	RAW_FILE_NAME(File Name )=20240809_JV141_14
SUBJECT_SAMPLE_FACTORS           	-	SDHB KO RquA DMSO 3	Sample source:143b Cells | Sample source:SDHB KO RquA | Treatment:DMSO	RAW_FILE_NAME(File Name )=20240809_JV141_15
SUBJECT_SAMPLE_FACTORS           	-	SDHB KO RquA Breq 1	Sample source:143b Cells | Sample source:SDHB KO RquA | Treatment:Brequinar	RAW_FILE_NAME(File Name )=20240809_JV141_16
SUBJECT_SAMPLE_FACTORS           	-	SDHB KO RquA Breq 2	Sample source:143b Cells | Sample source:SDHB KO RquA | Treatment:Brequinar	RAW_FILE_NAME(File Name )=20240809_JV141_17
SUBJECT_SAMPLE_FACTORS           	-	SDHB KO RquA Breq 3	Sample source:143b Cells | Sample source:SDHB KO RquA | Treatment:Brequinar	RAW_FILE_NAME(File Name )=20240809_JV141_18
#COLLECTION
CO:COLLECTION_SUMMARY            	Media was aspirated from the plates and then the cells were washed with 1x PBS
CO:COLLECTION_SUMMARY            	twice. The plate was then transferred to dry ice and 500 µL of 80% HPLC-grade
CO:COLLECTION_SUMMARY            	methanol (Sigma) 20% HPLC-grade water (Sigma) was added to each well. The wells
CO:COLLECTION_SUMMARY            	were placed in a -80 freezer to incubate for 15 minutes. The plates are taken
CO:COLLECTION_SUMMARY            	out of the freezer one at a time and placed back on dry ice. The cells were then
CO:COLLECTION_SUMMARY            	scraped and transferred to a new tube. Each well was washed with an additional
CO:COLLECTION_SUMMARY            	300 µL of 80% HPLC-grade methanol (Sigma) 20% HPLC-grade water (Sigma) and
CO:COLLECTION_SUMMARY            	collected into the same tube as the initial lysis.
CO:SAMPLE_TYPE                   	Cultured cells
#TREATMENT
TR:TREATMENT_SUMMARY             	Cells were seeded in complete DMEM 96 hours prior to tracing so that wells
TR:TREATMENT_SUMMARY             	reached 75% confluence at time of experiment. DMEM containing 10% FBS, 1%
TR:TREATMENT_SUMMARY             	penicillin and streptomycin, and 0.1 mg/mL uridine (Sigma) was used when seeding
TR:TREATMENT_SUMMARY             	the experiment. 72 hours prior, the media was changed to DMEM containing 10%
TR:TREATMENT_SUMMARY             	FBS, 1% penicillin and streptomycin, and 10 mM aspartate with the pH adjusted to
TR:TREATMENT_SUMMARY             	7.4 along with 1uL of either DMSO or 10mM of brequinar. 6 hours prior to
TR:TREATMENT_SUMMARY             	metabolite isolation, the cells were treated with DMEM containing 10% FBS, 1%
TR:TREATMENT_SUMMARY             	penicillin and streptomycin, and 10 mM 13C4-aspartate (Sigma) and the pH
TR:TREATMENT_SUMMARY             	adjusted to 7.4 with the relevant treatments.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Once the samples were collected, they were then vortexed at 4° C for 10 minutes
SP:SAMPLEPREP_SUMMARY            	and centrifuged at 21,300 x g for 10 minutes at 4° C. Supernatants were
SP:SAMPLEPREP_SUMMARY            	transferred to a new tube and dried down in a Refrigerated CentriVap Benchtop
SP:SAMPLEPREP_SUMMARY            	Vacuum Concentrator connected to a CentriVap-105 Cold Trap (Labconco). After
SP:SAMPLEPREP_SUMMARY            	being dried down, pellets were stored in a -20° C freezer until ready to run on
SP:SAMPLEPREP_SUMMARY            	the polar LC-MS method.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	HILIC
CH:INSTRUMENT_NAME               	Thermo Vanquish
CH:COLUMN_NAME                   	Merck SeQuant ZIC-HILIC (150 x 2.1mm,5um)
CH:SOLVENT_A                     	100% water; 0.1% ammonium hydroxide; 20mM ammonium carbonate
CH:SOLVENT_B                     	100% acetonitrile
CH:FLOW_GRADIENT                 	20 min, 80% - 20% B; 0.5 min, 20% - 80% B; 7.5min, 80% B
CH:FLOW_RATE                     	0.15ml/min
CH:COLUMN_TEMPERATURE            	25
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Thermo Q Exactive Plus Orbitrap
MS:INSTRUMENT_TYPE               	Orbitrap
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	POSITIVE
MS:MS_COMMENTS                   	The mass spectrometer was set to full scan (70-1000 m/z), with the spray voltage
MS:MS_COMMENTS                   	set to 4.0 kV, heated capillary to 350°C, and the HESI probe at 30 °C. The
MS:MS_COMMENTS                   	sheath gas flow was set at 10 units, auxiliary gas at 1 units, and sweep gas
MS:MS_COMMENTS                   	flow at 1 unit. The resolution of scan was set to 70,000, AGC target to 1x106,
MS:MS_COMMENTS                   	and maximum injection time at 20 msec. Data acquired by Thermo Fisher's Xcalibur
MS:MS_COMMENTS                   	software and analyzed by their Tracefinder software. The raw files provided
MS:MS_COMMENTS                   	contain data from both positive and negative ion mode.
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	peak area
MS_METABOLITE_DATA_START
Samples	WT DMSO 1	WT DMSO 2	WT DMSO 3	WT Breq 1	WT Breq 2	WT Breq 3	RquA DMSO 1	RquA DMSO 2	RquA DMSO 3	RquA Breq 1	RquA Breq 2	RquA Breq 3	SDHB KO RquA DMSO 1	SDHB KO RquA DMSO 2	SDHB KO RquA DMSO 3	SDHB KO RquA Breq 1	SDHB KO RquA Breq 2	SDHB KO RquA Breq 3
Factors	Sample source:143b Cells | Sample source:WT | Treatment:DMSO	Sample source:143b Cells | Sample source:WT | Treatment:DMSO	Sample source:143b Cells | Sample source:WT | Treatment:DMSO	Sample source:143b Cells | Sample source:WT | Treatment:Brequinar	Sample source:143b Cells | Sample source:WT | Treatment:Brequinar	Sample source:143b Cells | Sample source:WT | Treatment:Brequinar	Sample source:143b Cells | Sample source:RquA | Treatment:DMSO	Sample source:143b Cells | Sample source:RquA | Treatment:DMSO	Sample source:143b Cells | Sample source:RquA | Treatment:DMSO	Sample source:143b Cells | Sample source:RquA | Treatment:Brequinar	Sample source:143b Cells | Sample source:RquA | Treatment:Brequinar	Sample source:143b Cells | Sample source:RquA | Treatment:Brequinar	Sample source:143b Cells | Sample source:SDHB KO RquA | Treatment:DMSO	Sample source:143b Cells | Sample source:SDHB KO RquA | Treatment:DMSO	Sample source:143b Cells | Sample source:SDHB KO RquA | Treatment:DMSO	Sample source:143b Cells | Sample source:SDHB KO RquA | Treatment:Brequinar	Sample source:143b Cells | Sample source:SDHB KO RquA | Treatment:Brequinar	Sample source:143b Cells | Sample source:SDHB KO RquA | Treatment:Brequinar
Glutathione	957651322.1	678449909.6	430006621.2	763367000.5	799182933.9	119673356.2	645813941.3	779754010.9	674886861.3	798004696.1	844874610.9	462782598.7	321323885.9	345216100.7	166509822.9	278646188.6	266904789.5	231883018
Oxidized glutathione	44760844.22	52801395.15	58956190.19	67889600.02	66789634.25	11790072.03	34562578.58	46808250.54	39414803.39	40215283.82	32510672.04	19092868.24	30709751.44	32149343.75	24947068.93	40582847.9	37295382.84	20436930.34
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	Retention index	Quantified m/z	PubChem ID	KEGG ID
Glutathione	8.8	308.0911	124886	C00051
Oxidized glutathione	11	613.1592	65359	C00127
METABOLITES_END
#END